Literature DB >> 26302887

Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia.

Vivian P Lara1, Paulo Caramelli2, Antônio L Teixeira2, Maira T Barbosa2, Karoline C Carmona2, Henrique C Guimarães2, Maria G Carvalho1, Ana P Fernandes1, Karina B Gomes3.   

Abstract

BACKGROUND: Population aging is a global phenomenon whose main consequence is the increase of chronic degenerative diseases, including dementia. The aim of this case-control study was to evaluate the laboratorial parameters lipid profile, cortisol, and apolipoprotein E (APOE) gene genotype, comparing cognitively healthy controls and subjects with cognitive impairment no dementia (CIND) and dementia in a group of elderly people.
METHODS: Three hundred and nine individuals enrolled in the Pietà Study (Brazil) were divided into three groups: control (n = 158), CIND (n = 92), and dementia (n = 59). Participants were interviewed, went through examination, and had blood samples taken.
RESULTS: Age and APOE showed significant differences among the groups, while sex and lipid profile did not. According to multivariate regression logistic analyses, higher cortisol levels, lower high-density lipoprotein (HDL-c) and very low-density lipoprotein (VLDL-c), presence of ε4 allele of APOE, and aging were associated with CIND and dementia.
CONCLUSION: These laboratorial parameters are risk factors associated to CIND and dementia in the elderly people and should be investigated in order to develop strategies to prevent or delay the onset of dementia in the oldest-old populations.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  APOE polymorphisms; cognitive impairment no dementia; cortisol; dementia; lipid profile

Mesh:

Substances:

Year:  2015        PMID: 26302887      PMCID: PMC6806720          DOI: 10.1002/jcla.21865

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  49 in total

Review 1.  Mild cognitive impairment.

Authors:  Serge Gauthier; Barry Reisberg; Michael Zaudig; Ronald C Petersen; Karen Ritchie; Karl Broich; Sylvie Belleville; Henry Brodaty; David Bennett; Howard Chertkow; Jeffrey L Cummings; Mony de Leon; Howard Feldman; Mary Ganguli; Harald Hampel; Philip Scheltens; Mary C Tierney; Peter Whitehouse; Bengt Winblad
Journal:  Lancet       Date:  2006-04-15       Impact factor: 79.321

2.  Relationships between cholesterol, apolipoprotein E polymorphism and dementia: a cross-sectional analysis from the PAQUID study.

Authors:  M Bonarek; P Barberger-Gateau; L Letenneur; V Deschamps; A Iron; B Dubroca; J F Dartigues
Journal:  Neuroepidemiology       Date:  2000 May-Jun       Impact factor: 3.282

3.  Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI.

Authors:  J E Hixson; D T Vernier
Journal:  J Lipid Res       Date:  1990-03       Impact factor: 5.922

4.  Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.

Authors:  Miia Kivipelto; Tiia Ngandu; Laura Fratiglioni; Matti Viitanen; Ingemar Kåreholt; Bengt Winblad; Eeva-Liisa Helkala; Jaakko Tuomilehto; Hilkka Soininen; Aulikki Nissinen
Journal:  Arch Neurol       Date:  2005-10

5.  HPA axis dysregulation associated to apolipoprotein E4 genotype in Alzheimer's disease.

Authors:  Francisco J Gil-Bea; Barbara Aisa; Alina Solomon; Maite Solas; Maria del Carmen Mugueta; Bengt Winblad; Miia Kivipelto; Angel Cedazo-Mínguez; María J Ramírez
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Increased apolipoprotein B serum concentration in Alzheimer's disease.

Authors:  P Caramelli; R Nitrini; R Maranhão; A C Lourenço; M C Damasceno; C Vinagre; B Caramelli
Journal:  Acta Neurol Scand       Date:  1999-07       Impact factor: 3.209

7.  Association between high-density lipoprotein and cognitive impairment in the oldest old.

Authors:  Eric van Exel; Anton J M de Craen; Jacobijn Gussekloo; Peter Houx; Annetje Bootsma-van der Wiel; Peter W Macfarlane; Gerard J Blauw; Rudi G J Westendorp
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

Review 8.  Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors.

Authors:  Raj N Kalaria; Gladys E Maestre; Raul Arizaga; Robert P Friedland; Doug Galasko; Kathleen Hall; José A Luchsinger; Adesola Ogunniyi; Elaine K Perry; Felix Potocnik; Martin Prince; Robert Stewart; Anders Wimo; Zhen-Xin Zhang; Piero Antuono
Journal:  Lancet Neurol       Date:  2008-07-28       Impact factor: 44.182

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

10.  No evidence of a longitudinal association between diurnal cortisol patterns and cognition.

Authors:  Archana Singh-Manoux; Aline Dugravot; Alexis Elbaz; Martin Shipley; Mika Kivimaki; Meena Kumari
Journal:  Neurobiol Aging       Date:  2014-03-20       Impact factor: 4.673

View more
  4 in total

1.  Sex-dependent difference in the relationship between adipose-tissue cholesterol efflux and estradiol concentrations in young healthy humans.

Authors:  Fatima Iqbal; William J Durham; Ayyash Melhem; Saleem Raslan; Tony T Tran; Traver J Wright; Rabia Asghar; Ken Fujise; Elena Volpi; Labros Sidossis; Nicola Abate; Melinda Sheffield-Moore; Demidmaa Tuvdendorj
Journal:  Int J Dev Neurosci       Date:  2017-07-12       Impact factor: 2.457

2.  The relationship between ApoE gene polymorphism and the efficacy of statins controlling hyperlipidemia.

Authors:  Cong Cai; Zhongzheng Wen; Linrui Li
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

3.  Causal association of circulating cholesterol levels with dementia: a mendelian randomization meta-analysis.

Authors:  Xiaoyu Zhang; Qiuyue Tian; Di Liu; Tao Geng; Xizhu Xu; Siqi Ge; Deqiang Zheng; Lijuan Wu; Manshu Song; Haifeng Hou; Wei Wang; Youxin Wang
Journal:  Transl Psychiatry       Date:  2020-05-12       Impact factor: 6.222

4.  Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts.

Authors:  Juho Tynkkynen; Vincent Chouraki; Sven J van der Lee; Jussi Hernesniemi; Qiong Yang; Shuo Li; Alexa Beiser; Martin G Larson; Katri Sääksjärvi; Martin J Shipley; Archana Singh-Manoux; Robert E Gerszten; Thomas J Wang; Aki S Havulinna; Peter Würtz; Krista Fischer; Ayse Demirkan; M Arfan Ikram; Najaf Amin; Terho Lehtimäki; Mika Kähönen; Markus Perola; Andres Metspalu; Antti J Kangas; Pasi Soininen; Mika Ala-Korpela; Ramachandran S Vasan; Mika Kivimäki; Cornelia M van Duijn; Sudha Seshadri; Veikko Salomaa
Journal:  Alzheimers Dement       Date:  2018-03-06       Impact factor: 21.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.